Parties agreed to settle litigation by way of CCAA Plan of Arrangement

VAUGHAN, ON, Jan. 20, 2021 /CNW/ – CannTrust Holdings Inc. (“CannTrust” or the “Company”) (unlisted) announced today that it has entered into a Restructuring Support Agreement (“RSA”) with plaintiffs who have commenced litigation in Canada and the United States (the “Securities Claims”) asserting claims against CannTrust and others on behalf of a global class of CannTrust shareholders (together, the “Securities Claimants”) and their legal counsel. The RSA provides a comprehensive framework for settling the Securities Claims under a Court-approved plan of compromise, arrangement and reorganization (“Plan of Arrangement”) pursuant to the Companies’ Creditors Arrangement Act (Canada) (“CCAA”).

“Today’s announcement represents a significant milestone towards the resolution of substantially all of the civil litigation claims that were filed against CannTrust following the Company’s non-compliance with certain Health Canada regulations,” said Greg Guyatt, Chief Executive Officer at CannTrust. “Although much work remains to conclude the matters contemplated by the RSA, I am pleased that, in addition to relaunching our medical and recreational businesses, we are also making further tangible progress to exit from the CCAA and put CannTrust in a position to be a successful player in the cannabis industry.”

The RSA contemplates that the Securities Claims will be settled as part of a broader restructuring of the Company and its subsidiaries pursuant to a Plan of Arrangement that will be completed under the CCAA. Implementation of the Plan of Arrangement will be subject to several conditions, including negotiation of mutually satisfactory definitive documentation and approval of the Plan of Arrangement by the Ontario Superior Court of Justice (Commercial List) (the “Ontario Court”) in the CCAA proceedings. The RSA requires the parties to negotiate in good faith to finalize the terms of definitive agreements and the Plan of Arrangement on terms consistent with the terms of the RSA and to cooperate in good faith during the mediation ordered by the Ontario Court on May 8, 2020 (the “Mediation”). In addition, the RSA requires the other parties to cooperate with CannTrust to pursue and support the settlement of the Securities Claims in the manner contemplated by the RSA.

The RSA also contemplates the resolution, pursuant to the Plan of Arrangement, of all claims against CannTrust and certain other defendants in the Securities Claims, including Greg Guyatt, Mark Dawber, John Kaden, Robert Marcovitch, Shawna Page, Mitchell Sanders and Cajun Capital Corporation. Upon the implementation of the Plan of Arrangement, CannTrust will, among other things, pay CAD $50 million into a trust that will be established for the benefit of the Securities Claimants. The RSA permits other defendants to elect to join in the settlement of the Securities Claims pursuant to the Plan of Arrangement, subject to certain conditions.

The Company stated that its cash position at January 19, 2021 was approximately CAD $78 million.

CannTrust also expressed its appreciation for the tireless efforts and wise counsel provided to all parties to the RSA by retired Associate Chief Justice of Ontario, Dennis O’Connor, OC, OOnt, who has supervised the Mediation.

CannTrust remains under CCAA protection to facilitate its efforts to resolve its civil litigation claims and complete its review of strategic alternatives, which includes a review of financing options. Aspects of the ongoing efforts remain confidential, and the Company is unable to predict with any certainty either their timing or outcome. In the meantime, the reinstatement of its cannabis licenses and the restoration of its ongoing operations, CannTrust’s re-entry into the Canadian recreational and medical cannabis business segments and its entry into the RSA are essential to the Company’s focus on rebuilding its franchise. For more information about CannTrust’s CCAA proceedings, please visit:

About CannTrust

CannTrust is a federally regulated licensed cannabis producer. We are proudly Canadian, operating a portfolio of brands including estora, Liiv and Synr.g, specifically designed to surprise and delight patients and consumers.

At CannTrust, we are committed to providing an exceptional customer experience, as well as consistent and quality products through standardized processes. Our greenhouse produces Grade A cannabis flower, which is currently sold in dried flower, oil drops and capsule formats. Founded in 2013, our continued success in the medical cannabis market and subsequent expansion into the recreational business, led to us being named Licensed Producer of the Year at the Canadian Cannabis Awards 2018.

CannTrust is committed to research and innovation, investing in developing technologies for new products in the medical, recreational, and wellness markets, while contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of Canadian Securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable United States safe harbor laws, and such statements are based upon CannTrust’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events.

Forward-looking information and forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

The forward-looking information and statements in this news release include statements relating to the expectation that CannTrust will settle certain civil litigation claims and emerge from creditor protection under the CCAA. Forward-looking information and statements necessarily involve known and unknown risks, including, without limitation: the outcome of the Company’s contingent liabilities; the impact of potential regulatory and other investigations; the Company’s review of strategic alternatives; risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States and elsewhere; the cannabis industry in Canada generally; and, the ability of CannTrust to implement its business strategies.

Any forward-looking information and statements speak only as of the date on which they are made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking information and statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust’s Annual Information Form dated March 28, 2019 (the “AIF”) and filed with the applicable Canadian securities regulatory authorities on SEDAR at and filed as an exhibit CannTrust’s Form 40-F annual report under the United States Securities Exchange Act of 1934, as amended, with the United States Securities and Exchange Commission on EDGAR at (the “March 2019 Form 40-F”). The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information or statements. Readers are also reminded that CannTrust remains in default of its periodic disclosure requirements under applicable securities laws and stock exchange requirements, that its most recent AIF, Form 40-F and other disclosures do not reflect all risk factors that currently face the Company, and that the Company has not completed or filed the restatements of the financial statements included in the AIF or the March 2019 Form 40-F or otherwise filed an amendment to such Form 40-F, and that the Company has determined not to correct its prior filings or make any further filings in respect of periodic disclosure requirements under applicable securities laws and stock exchange requirements. None of the Company’s securities is listed for trading on any stock exchange in any jurisdiction and, in Canada, trading in the Company’s securities is subject to a cease-trade order issued on April 13, 2020 by the Ontario Securities Commission for CannTrust’s failure to comply with its disclosure obligations under applicable securities laws.


Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.


Subscribe Now


© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest